Optimization implementation and efficacy evaluation of enteral nutrition care for patients during chemoradiotherapy
肿瘤放化疗期间患者肠道营养护理的优化实施与疗效评估

摘要

目的 探讨为肿瘤放化疗期间的患者进行肠道营养护理的优化实施策略，并讨论其实施效果。方法研究从2025年1月开始，收集研究样本共100例，均为肿瘤放化疗治疗患者，结束时间为2026年1月。将在此期间收集到的100例患者进行分组，对照组中有50例患者，实施常规营养支持护理，其余患者为观察组，实施优化肠道营养护理方案。就患者营养状况指标、肠道功能指标、免疫功能指标、住院天数及体重进行比较，同时对比两组患者放化疗期间肠道不良反应发生率及护理满意度。结果 观察组患者经过优化肠道营养护理实施后，营养状况指标及肠道功能指标较优，患者体重较高（P<0.05）；观察组患者免疫功能和护理满意度明显较高，住院天数较短，肠道不良反应发生率较低（P<0.05）。结论 为肿瘤放化疗患者实施优化后的肠道营养护理方案能够显著改善患者营养状况和肠道功能，提高免疫功能和护理满意度，降低不良反应发生率，缩短患者治疗周期。

Abstract

Objective To explore the optimization strategies for enteral nutrition care during chemoradiotherapy in cancer patients and to evaluate their implementation effects.
Methods A total of 100 cases of patients undergoing chemoradiotherapy were enrolled from January 2025 to January 2026. The patients were divided into two groups: the control group (n=50) received conventional nutritional support care, while the observation group (n=50) received optimized enteral nutrition care. Comparison was made between the two groups in terms of nutritional status indicators, intestinal function indicators, immune function indicators, length of hospital stay, and body weight. Additionally, the incidence of adverse intestinal reactions and nursing satisfaction were compared between the two groups during the chemoradiotherapy period.
Results After the implementation of optimized enteral nutrition care, the observation group showed superior nutritional status and intestinal function indicators, with higher body weight (P<0.05). The observation group also demonstrated significantly higher immune function and nursing satisfaction, shorter length of hospital stay, and lower incidence of adverse intestinal reactions (P<0.05).
Conclusion   Implementing an optimized enteral nutrition nursing protocol for cancer patients undergoing radiotherapy and chemotherapy can significantly improve their nutritional status and intestinal function, enhance immune function and nursing satisfaction, reduce the incidence of adverse reactions, and shorten the treatment cycle.